Affiliation: GlaxoSmithKline Research and Development
- The FDA guidance for industry on PROs: the point of view of a pharmaceutical companyFabio Arpinelli
Health Technology Assessment, Medical Department, GSK S p A Verona, Italy
Health Qual Life Outcomes 4:85. 2006..Moreover, prescribing doctors and payers could benefit from subjective information to better define the value of drugs...